Mari Dallas

1.5k total citations
31 papers, 954 citations indexed

About

Mari Dallas is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Mari Dallas has authored 31 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 19 papers in Immunology and 8 papers in Oncology. Recurrent topics in Mari Dallas's work include Hematopoietic Stem Cell Transplantation (19 papers), Immune Cell Function and Interaction (15 papers) and T-cell and B-cell Immunology (10 papers). Mari Dallas is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Immune Cell Function and Interaction (15 papers) and T-cell and B-cell Immunology (10 papers). Mari Dallas collaborates with scholars based in United States. Mari Dallas's co-authors include Wing Leung, Brandon M. Triplett, Christine Hartford, Ashok Srinivasan, Irwin D. Bernstein, David Shook, Barbara Varnum‐Finney, Joseph Laver, Paul G. Thomas and Guolian Kang and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Mari Dallas

29 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mari Dallas United States 14 545 397 298 232 165 31 954
Andrea Jarisch Germany 18 364 0.7× 195 0.5× 179 0.6× 177 0.8× 107 0.6× 62 776
Stéphanie Nguyen France 17 457 0.8× 347 0.9× 214 0.7× 144 0.6× 118 0.7× 49 791
Christopher Gamper United States 17 557 1.0× 474 1.2× 208 0.7× 122 0.5× 303 1.8× 40 1.2k
Craig Howe United States 9 714 1.3× 302 0.8× 186 0.6× 143 0.6× 100 0.6× 13 909
Jean‐Yves Cahn France 11 698 1.3× 221 0.6× 217 0.7× 219 0.9× 169 1.0× 14 902
Jeanette Carreras United States 15 485 0.9× 204 0.5× 345 1.2× 93 0.4× 95 0.6× 39 988
H. Baurmann Germany 18 757 1.4× 215 0.5× 211 0.7× 294 1.3× 180 1.1× 61 1.2k
Barbarella Lucarelli Italy 13 531 1.0× 419 1.1× 214 0.7× 64 0.3× 66 0.4× 28 860
Udo zur Stadt Germany 14 641 1.2× 211 0.5× 240 0.8× 663 2.9× 307 1.9× 37 1.2k
Shunro Kai Japan 16 778 1.4× 336 0.8× 277 0.9× 133 0.6× 73 0.4× 48 986

Countries citing papers authored by Mari Dallas

Since Specialization
Citations

This map shows the geographic impact of Mari Dallas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Dallas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Dallas more than expected).

Fields of papers citing papers by Mari Dallas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari Dallas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Dallas. The network helps show where Mari Dallas may publish in the future.

Co-authorship network of co-authors of Mari Dallas

This figure shows the co-authorship network connecting the top 25 collaborators of Mari Dallas. A scholar is included among the top collaborators of Mari Dallas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Dallas. Mari Dallas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennedy, Mark, et al.. (2025). Patient Derived 3D Tumoroids are Effectively Killed by Expanded Primary and iPSC-derived NK cells. Cytotherapy. 27(5). S181–S181. 1 indexed citations
2.
Epperly, Rebecca, Emily Zeng, Renee Madden, et al.. (2024). Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy. Transplantation and Cellular Therapy. 30(5). 526.e1–526.e11.
3.
Pereda, María A., et al.. (2022). Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia. Frontiers in Immunology. 13. 1055473–1055473. 5 indexed citations
4.
Zamora, Anthony E., Jeremy Chase Crawford, E. Kaitlynn Allen, et al.. (2019). Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8 + T cell responses. Science Translational Medicine. 11(498). 59 indexed citations
5.
Guo, Xi-zhi J., et al.. (2016). Rapid cloning, expression, and functional characterization of paired αβ and γδ T-cell receptor chains from single-cell analysis. Molecular Therapy — Methods & Clinical Development. 3. 15054–15054. 37 indexed citations
6.
Triplett, Brandon M., Guolian Kang, Shane J. Cross, et al.. (2015). Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion. Blood. 126(23). 624–624. 1 indexed citations
7.
Rubnitz, Jeffrey E., Hiroto Inaba, Guolian Kang, et al.. (2015). Natural killer cell therapy in children with relapsed leukemia. Pediatric Blood & Cancer. 62(8). 1468–1472. 40 indexed citations
8.
Kang, Guolian, et al.. (2014). Gamma Delta T Cell Reconstitution Is Associated with Fewer Infections and Improved Event-Free Survival after Hematopoietic Stem Cell Transplantation for Pediatric Leukemia. Biology of Blood and Marrow Transplantation. 21(1). 130–136. 87 indexed citations
9.
Srinivasan, Ashok, John C. Panetta, Shane J. Cross, et al.. (2014). Phase I Study of the Safety and Pharmacokinetics of Plerixafor in Children Undergoing a Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Leukemia. Biology of Blood and Marrow Transplantation. 20(8). 1224–1228. 10 indexed citations
10.
Tomchuck, Suzanne L., Wing Leung, & Mari Dallas. (2013). Isolation, Expansion & Function of Cord Blood Natural Killer Cells. Biology of Blood and Marrow Transplantation. 19(2). S208–S208. 1 indexed citations
11.
Rujkijyanont, Piya, Christopher M. Morris, Guolian Kang, et al.. (2013). Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia. Blood Cancer Journal. 3(8). e137–e137. 37 indexed citations
12.
Leung, Wing, Ching‐Hon Pui, Elaine Coustan‐Smith, et al.. (2012). Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood. 120(2). 468–472. 132 indexed citations
13.
Shook, David, Brandon M. Triplett, Ashok Srinivasan, et al.. (2012). Successful Allogeneic Hematopoietic Cell Engraftment after a Minimal Conditioning Regimen in Children with Relapsed or Refractory Solid Tumors. Biology of Blood and Marrow Transplantation. 19(2). 291–297. 5 indexed citations
14.
Triplett, Brandon M., Chong Wang, Jie Yang, et al.. (2012). Effects of Conditioning Regimens and T Cell Depletion in Hematopoietic Cell Transplantation for Primary Immune Deficiency. Biology of Blood and Marrow Transplantation. 18(12). 1911–1920. 7 indexed citations
15.
16.
17.
Dallas, Mari, Colleen Delaney, Barbara Varnum‐Finney, & Irwin D. Bernstein. (2008). Facilitation of Thymic and Bone Marrow Engraftment by Hematopoietic Progenitors Expanded Ex-Vivo Using the Notch Ligand Delta1. Blood. 112(11). 3498–3498. 1 indexed citations
18.
19.
Varnum‐Finney, Barbara, Mari Dallas, Keizo Kato, & Irwin D. Bernstein. (2007). Notch target Hes5 ensures appropriate Notch induced T- versus B-cell choices in the thymus. Blood. 111(5). 2615–2620. 17 indexed citations
20.
Dallas, Mari, Barbara Varnum‐Finney, Colleen Delaney, Keizo Kato, & Irwin D. Bernstein. (2005). Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells. The Journal of Experimental Medicine. 201(9). 1361–1366. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Jarisch Breakdown of academic impact, for papers by Stéphanie Nguyen Breakdown of academic impact, for papers by Christopher Gamper Breakdown of academic impact, for papers by Craig Howe Breakdown of academic impact, for papers by Jean‐Yves Cahn Breakdown of academic impact, for papers by Jeanette Carreras Breakdown of academic impact, for papers by H. Baurmann Breakdown of academic impact, for papers by Barbarella Lucarelli Breakdown of academic impact, for papers by Udo zur Stadt Breakdown of academic impact, for papers by Shunro Kai
Rankless by CCL
2026